EPW
EMN icon

Evolve Private Wealth’s Eastman Chemical EMN Stock Holding History

Evolve Private Wealth’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
+5,000
New +$366K 0.02% 665

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Evolve Private Wealth's EMN Position: Q2 2026 in Review

Evolve Private Wealth opened a new position in Eastman Chemical (EMN) in Q2 2026: 5,000 shares worth $339K. The stake represents 0.02% of the portfolio and ranks #665 among its holdings.

642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Evolve Private Wealth held 5,000 shares of Eastman Chemical worth $339K as of Q2 2026.
  • Eastman Chemical was a new Evolve Private Wealth position in Q2 2026.
  • Eastman Chemical made up 0.02% of Evolve Private Wealth's portfolio in Q2 2026, its #665 holding.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.